1 week Ago By ABMN Staff
Shares of Astera Labs, Inc. ( NASDAQ:ALAB – Get Free Report ) have been assigned a consensus recommendation of “Buy” from the twelve ratings firms that are presently covering the firm, Marketbeat.com reports.
Twelve investment analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have issued a report on the stock in the last year is $98.67.
A number of research analysts have issued reports on the company. JPMorgan Chase & Co. upped their price objective on Astera Labs from $70.
00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Roth Mkm increased their price target on shares of Astera Labs from $80.
00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Stifel Nicolaus lifted their price objective on shares of Astera Labs from $80.
00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Morgan Stanley boosted their target price on shares of Astera Labs from $94.
00 to $142.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Needham & Company LLC restated a “buy” rating and set a $65.
00 price target on shares of Astera Labs in a research note on Wednesday, October 9th. Get Our Latest Report on Astera Labs Insider Activity at Astera Labs Institutional Inflows and Outflows Several institutional investors have recently made changes to their positions in the company. Strategic Blueprint LLC grew its position in Astera Labs by 3.
6% during the third quarter. Strategic Blueprint LLC now owns 5,684 shares of the company’s stock worth $298,000 after buying an additional 195 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Astera Labs by 5.
7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company’s stock worth $277,000 after purchasing an additional 284 shares in the last quarter. Hollencrest Capital Management bought a new position in shares of Astera Labs in the third quarter worth approximately $26,000.
Venturi Wealth Management LLC raised its stake in Astera Labs by 26.3% in the third quarter. Venturi Wealth Management LLC now owns 2,400 shares of the company’s stock valued at $126,000 after purchasing an additional 500 shares in the last quarter.
Finally, US Bancorp DE bought a new stake in Astera Labs during the third quarter valued at approximately $46,000. Institutional investors own 60.47% of the company’s stock.
Astera Labs Stock Up 2.6 % Shares of ALAB stock opened at $135.57 on Friday.
Astera Labs has a 52-week low of $36.22 and a 52-week high of $138.14.
The company has a 50-day simple moving average of $95.41 and a two-hundred day simple moving average of $66.47.
Astera Labs ( NASDAQ:ALAB – Get Free Report ) last released its earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.
17 by $0.06. The company had revenue of $113.
10 million during the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative return on equity of 15.
57% and a negative net margin of 30.69%. Astera Labs’s quarterly revenue was up 47.
1% on a year-over-year basis. Equities research analysts predict that Astera Labs will post -0.45 earnings per share for the current year.
About Astera Labs ( Get Free Report Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. See Also Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.
com's FREE daily email newsletter ..
